Home > Insider Trading > Filing (0000950170-24-038657)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1733257	Finch Therapeutics Group Inc.	FNCH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1193038	A Jeffery Smisek	C/O Finch Therapeutics Group, Inc. 75 State Street, Suite 100 Boston MA 02109		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-03-28	6,642	$2.57	0	No	4	S	Direct
Common Stock	Disposition	2024-03-28	1,600	$2.61	6,512	No	4	S	Indirect	By spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	By spouse

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	40,260	Indirect	See footnote

Footnotes

Represents the weighted-average price of shares sold by the broker on behalf of the Reporting Person. The broker sold, in the aggregate on behalf of such Reporting Person, 6,642 shares in transactions ranging from $2.48 to $2.75 with a weighted-average price of $2.57. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Represents the weighted-average price of shares sold by the broker on behalf of the Reporting Person's spouse. The broker sold, in the aggregate on behalf of such Reporting Person's spouse, 1,600 shares in transactions ranging from $2.56 to $2.76 with a weighted-average price of $2.61. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The securities are held by Flight Partners Management LLC ("Flight Partners Capital"). The Reporting Person is the president of Flight Partners Capital.